Symbol:
Npr2
Name:
natriuretic peptide receptor 2
RGD ID:
620851
Description:
Enables peptide hormone binding activity. Involved in cGMP-mediated signaling; positive regulation of signal transduction; and wound healing. Predicted to be located in synapse. Predicted to be active in several cellular components, including cilium; neuron projection; and nucleus. Human ortholog(s) of this gene implicated in Miura type epiphyseal chondrodysplasia; acromesomelic dysplasia, Maroteaux type; and essential hypertension. Orthologous to human NPR2 (natriuretic peptide receptor 2); PARTICIPATES IN C-type natriuretic peptide signaling pathway; purine metabolic pathway; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-sulfonyldiphenol; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
ANP-B; ANPR-B; ANPRB; atrial natriuretic peptide B-type receptor; atrial natriuretic peptide receptor 2; atrial natriuretic peptide receptor B; atrial natriuretic peptide receptor type B; GC-B; guanylate cyclase B; natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B); natriuretic peptide receptor-B; NPR-B
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
NPR2 (natriuretic peptide receptor 2)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Npr2 (natriuretic peptide receptor 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Npr2 (natriuretic peptide receptor 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
NPR2 (natriuretic peptide receptor 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
NPR2 (natriuretic peptide receptor 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Npr2 (natriuretic peptide receptor 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
NPR2 (natriuretic peptide receptor 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
NPR2 (natriuretic peptide receptor 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Npr2 (natriuretic peptide receptor 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
NPR2 (natriuretic peptide receptor 2)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Npr2 (natriuretic peptide receptor 2)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
npr2 (natriuretic peptide receptor 2)
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
CG31183
Alliance
DIOPT (Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
gcy-28
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 62,678,197 - 62,697,360 (+) NCBI GRCr8 mRatBN7.2 5 57,883,171 - 57,901,590 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 57,883,171 - 57,901,580 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 59,863,179 - 59,881,665 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 61,681,991 - 61,700,479 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 61,653,242 - 61,671,683 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 59,128,186 - 59,147,321 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 59,128,315 - 59,147,255 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 63,652,957 - 63,672,114 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 5 60,107,563 - 60,127,960 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 5 60,107,741 - 60,128,139 (+) NCBI Celera 5 56,463,705 - 56,482,048 (+) NCBI Celera Cytogenetic Map 5 q22 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Npr2 Rat (1->4)-beta-D-glucan multiple interactions ISO Npr2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NPR2 mRNA CTD PMID:36331819 Npr2 Rat 1,1-dichloroethene decreases expression ISO Npr2 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of NPR2 mRNA CTD PMID:26682919 Npr2 Rat 1,2-dimethylhydrazine increases expression ISO Npr2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of NPR2 mRNA CTD PMID:22206623 Npr2 Rat 17beta-estradiol affects expression ISO NPR2 (Homo sapiens) 6480464 Estradiol affects the expression of NPR2 mRNA CTD PMID:14699072 Npr2 Rat 17beta-estradiol decreases expression ISO Npr2 (Mus musculus) 6480464 Estradiol results in decreased expression of NPR2 mRNA CTD PMID:39298647 Npr2 Rat 17beta-estradiol multiple interactions ISO NPR2 (Homo sapiens) 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of NPR2 mRNA more ... CTD PMID:20404318 and PMID:30165855 Npr2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of NPR2 mRNA CTD PMID:22298810 Npr2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Npr2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of NPR2 mRNA CTD PMID:21570461 and PMID:26377647 Npr2 Rat 2-hydroxypropanoic acid decreases expression ISO NPR2 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of NPR2 mRNA CTD PMID:30851411 Npr2 Rat 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Npr2 (Mus musculus) 6480464 3 more ... CTD PMID:19467301 Npr2 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO NPR2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NPR2 mRNA CTD PMID:28628672 Npr2 Rat 4,4'-sulfonyldiphenol decreases methylation ISO Npr2 (Mus musculus) 6480464 bisphenol S results in decreased methylation of NPR2 exon CTD PMID:33297965 Npr2 Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NPR2 mRNA CTD PMID:36041667 Npr2 Rat 4,4'-sulfonyldiphenol affects methylation ISO Npr2 (Mus musculus) 6480464 bisphenol S affects the methylation of NPR2 gene CTD PMID:31683443 Npr2 Rat 4,4'-sulfonyldiphenol increases methylation ISO NPR2 (Homo sapiens) 6480464 bisphenol S results in increased methylation of NPR2 gene CTD PMID:31601247 Npr2 Rat 4,4'-sulfonyldiphenol decreases expression ISO Npr2 (Mus musculus) 6480464 bisphenol S results in decreased expression of NPR2 mRNA CTD PMID:39298647 Npr2 Rat 4-hydroxyphenyl retinamide decreases expression ISO Npr2 (Mus musculus) 6480464 Fenretinide results in decreased expression of NPR2 mRNA CTD PMID:28973697 Npr2 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of NPR2 mRNA CTD PMID:30047161 Npr2 Rat acrolein multiple interactions ISO NPR2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of NPR2 mRNA CTD PMID:32845096 Npr2 Rat afimoxifene decreases response to substance ISO NPR2 (Homo sapiens) 6480464 NPR2 results in decreased susceptibility to afimoxifene CTD PMID:21233418 Npr2 Rat aflatoxin B1 decreases methylation ISO NPR2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of NPR2 gene and Aflatoxin B1 results in decreased methylation of NPR2 polyA tail CTD PMID:27153756 and PMID:30157460 Npr2 Rat Aflatoxin B2 alpha decreases methylation ISO NPR2 (Homo sapiens) 6480464 aflatoxin B2 results in decreased methylation of NPR2 intron CTD PMID:30157460 Npr2 Rat allethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NPR2 protein CTD PMID:34896426 Npr2 Rat amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of NPR2 mRNA CTD PMID:30047161 Npr2 Rat ammonia multiple interactions EXP 6480464 Ammonia inhibits the reaction [NPPC protein binds to NPR2 protein] CTD PMID:18222015 Npr2 Rat ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of NPR2 protein CTD PMID:16517024 Npr2 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NPR2 mRNA CTD PMID:16483693 Npr2 Rat amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of NPR2 mRNA CTD PMID:30779732 Npr2 Rat aristolochic acid A increases expression ISO NPR2 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of NPR2 mRNA CTD PMID:33212167 Npr2 Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of NPR2 gene CTD PMID:28931070 Npr2 Rat benzo[a]pyrene increases expression ISO Npr2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of NPR2 mRNA CTD PMID:22228805 Npr2 Rat bisphenol A increases expression ISO Npr2 (Mus musculus) 6480464 bisphenol A results in increased expression of NPR2 mRNA CTD PMID:26063408 Npr2 Rat bisphenol A decreases expression ISO NPR2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of NPR2 mRNA CTD PMID:36232920 Npr2 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NPR2 mRNA CTD PMID:36041667 Npr2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NPR2 mRNA CTD PMID:32145629 Npr2 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NPR2 mRNA CTD PMID:25181051 Npr2 Rat bisphenol AF decreases expression EXP 6480464 bisphenol AF results in decreased expression of NPR2 mRNA CTD PMID:27567155 Npr2 Rat bisphenol F multiple interactions ISO NPR2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NPR2 mRNA CTD PMID:28628672 Npr2 Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NPR2 mRNA CTD PMID:36041667 Npr2 Rat butanal decreases expression ISO NPR2 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of NPR2 mRNA CTD PMID:26079696 Npr2 Rat cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of NPR2 mRNA CTD PMID:33453195 Npr2 Rat carbamazepine affects expression ISO NPR2 (Homo sapiens) 6480464 Carbamazepine affects the expression of NPR2 mRNA CTD PMID:25979313 Npr2 Rat carbon nanotube decreases expression ISO Npr2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 Npr2 Rat crocidolite asbestos decreases expression ISO Npr2 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of NPR2 mRNA CTD PMID:29279043 Npr2 Rat cyclosporin A decreases methylation ISO NPR2 (Homo sapiens) 6480464 Cyclosporine results in decreased methylation of NPR2 promoter CTD PMID:27989131 Npr2 Rat cyhalothrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NPR2 protein CTD PMID:34896426 Npr2 Rat cypermethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NPR2 protein CTD PMID:34896426 Npr2 Rat dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [nitrofen results in increased expression of NPR2 mRNA] CTD PMID:10898224 Npr2 Rat dexamethasone multiple interactions ISO NPR2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NPR2 mRNA CTD PMID:28628672 Npr2 Rat diazinon increases methylation ISO NPR2 (Homo sapiens) 6480464 Diazinon results in increased methylation of NPR2 gene CTD PMID:22964155 Npr2 Rat Dibutyl phosphate affects expression ISO NPR2 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of NPR2 mRNA CTD PMID:37042841 Npr2 Rat dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of NPR2 mRNA CTD PMID:21266533 Npr2 Rat dioxygen multiple interactions ISO Npr2 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NPR2 mRNA CTD PMID:30529165 Npr2 Rat diuron increases expression EXP 6480464 Diuron results in increased expression of NPR2 mRNA CTD PMID:21551480 Npr2 Rat dorsomorphin multiple interactions ISO NPR2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NPR2 mRNA CTD PMID:27188386 Npr2 Rat doxorubicin decreases expression ISO NPR2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of NPR2 mRNA CTD PMID:29803840 Npr2 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of NPR2 mRNA CTD PMID:31464424 Npr2 Rat epoxiconazole decreases expression ISO Npr2 (Mus musculus) 6480464 epoxiconazole results in decreased expression of NPR2 mRNA CTD PMID:35436446 Npr2 Rat ethanol affects splicing ISO Npr2 (Mus musculus) 6480464 Ethanol affects the splicing of NPR2 mRNA CTD PMID:30319688 Npr2 Rat ethanol increases expression ISO Npr2 (Mus musculus) 6480464 Ethanol results in increased expression of NPR2 mRNA CTD PMID:30319688 Npr2 Rat fenamidone increases expression ISO Npr2 (Mus musculus) 6480464 fenamidone results in increased expression of NPR2 mRNA CTD PMID:27029645 Npr2 Rat fenthion decreases expression ISO Npr2 (Mus musculus) 6480464 Fenthion results in decreased expression of NPR2 mRNA CTD PMID:34813904 Npr2 Rat fenvalerate multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NPR2 protein CTD PMID:34896426 Npr2 Rat furan increases expression EXP 6480464 furan results in increased expression of NPR2 mRNA CTD PMID:27387713 Npr2 Rat indometacin multiple interactions ISO NPR2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NPR2 mRNA CTD PMID:28628672 Npr2 Rat lead(0) affects splicing ISO NPR2 (Homo sapiens) 6480464 Lead affects the splicing of NPR2 mRNA CTD PMID:28903495 Npr2 Rat leflunomide decreases expression ISO NPR2 (Homo sapiens) 6480464 leflunomide results in decreased expression of NPR2 mRNA CTD PMID:28988120 Npr2 Rat methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of NPR2 mRNA CTD PMID:30047161 Npr2 Rat methylisothiazolinone increases expression ISO NPR2 (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of NPR2 mRNA CTD PMID:31629900 Npr2 Rat N-nitrosodiethylamine increases expression ISO Npr2 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of NPR2 mRNA CTD PMID:17942915 Npr2 Rat N-nitrosodiethylamine decreases expression ISO Npr2 (Mus musculus) 6480464 Diethylnitrosamine results in decreased expression of NPR2 mRNA CTD PMID:24535843 Npr2 Rat N-nitrosodiethylamine multiple interactions ISO Npr2 (Mus musculus) 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of NPR2 mRNA] CTD PMID:17942915 Npr2 Rat nickel atom decreases expression ISO NPR2 (Homo sapiens) 6480464 Nickel results in decreased expression of NPR2 mRNA CTD PMID:24768652 Npr2 Rat nickel sulfate increases expression ISO NPR2 (Homo sapiens) 6480464 nickel sulfate results in increased expression of NPR2 mRNA CTD PMID:22714537 Npr2 Rat nitrofen increases expression EXP 6480464 nitrofen results in increased expression of NPR2 mRNA CTD PMID:10898224 Npr2 Rat nitrofen multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [nitrofen results in increased expression of NPR2 mRNA] CTD PMID:10898224 Npr2 Rat ozone multiple interactions ISO Npr2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of NPR2 mRNA CTD PMID:34911549 Npr2 Rat ozone multiple interactions ISO NPR2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of NPR2 mRNA CTD PMID:32845096 Npr2 Rat paracetamol affects expression ISO Npr2 (Mus musculus) 6480464 Acetaminophen affects the expression of NPR2 mRNA CTD PMID:17562736 Npr2 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of NPR2 mRNA CTD PMID:33387578 Npr2 Rat perfluorohexanesulfonic acid increases expression ISO Npr2 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of NPR2 mRNA CTD PMID:37995155 Npr2 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Npr2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NPR2 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of NPR2 mRNA CTD PMID:36331819 Npr2 Rat phenobarbital increases expression ISO Npr2 (Mus musculus) 6480464 Phenobarbital results in increased expression of NPR2 mRNA CTD PMID:19482888 Npr2 Rat phenobarbital multiple interactions ISO Npr2 (Mus musculus) 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NPR2 mRNA] CTD PMID:19482888 Npr2 Rat phosgene affects expression ISO Npr2 (Mus musculus) 6480464 Phosgene affects the expression of NPR2 mRNA CTD PMID:16300373 Npr2 Rat pirinixic acid multiple interactions ISO NPR2 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NPR2 mRNA CTD PMID:19710929 Npr2 Rat pirinixic acid decreases expression ISO Npr2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of NPR2 mRNA CTD PMID:23811191 Npr2 Rat potassium dichromate increases expression ISO Npr2 (Mus musculus) 6480464 Potassium Dichromate results in increased expression of NPR2 mRNA CTD PMID:23608068 Npr2 Rat pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of NPR2 mRNA CTD PMID:30047161 Npr2 Rat pyrethrins decreases expression EXP 6480464 Pyrethrins results in decreased expression of NPR2 protein CTD PMID:34896426 Npr2 Rat rac-lactic acid decreases expression ISO NPR2 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of NPR2 mRNA CTD PMID:30851411 Npr2 Rat raloxifene affects expression ISO NPR2 (Homo sapiens) 6480464 Raloxifene Hydrochloride affects the expression of NPR2 mRNA CTD PMID:14699072 Npr2 Rat raloxifene multiple interactions ISO NPR2 (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with ESR1 protein] results in increased expression of NPR2 mRNA and [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of NPR2 mRNA CTD PMID:19059307 Npr2 Rat rofecoxib decreases expression ISO NPR2 (Homo sapiens) 6480464 rofecoxib results in decreased expression of NPR2 mRNA CTD PMID:17070997 Npr2 Rat SB 431542 multiple interactions ISO NPR2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NPR2 mRNA CTD PMID:27188386 Npr2 Rat silver atom increases expression ISO Npr2 (Mus musculus) 6480464 Silver results in increased expression of NPR2 mRNA CTD PMID:27131904 Npr2 Rat silver(0) increases expression ISO Npr2 (Mus musculus) 6480464 Silver results in increased expression of NPR2 mRNA CTD PMID:27131904 Npr2 Rat sodium fluoride increases expression ISO Npr2 (Mus musculus) 6480464 Sodium Fluoride results in increased expression of NPR2 mRNA CTD PMID:27862939 Npr2 Rat sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of NPR2 mRNA CTD PMID:30047161 Npr2 Rat sulforaphane increases expression ISO NPR2 (Homo sapiens) 6480464 sulforaphane results in increased expression of NPR2 mRNA CTD PMID:31838189 Npr2 Rat sunitinib increases expression ISO NPR2 (Homo sapiens) 6480464 Sunitinib results in increased expression of NPR2 mRNA CTD PMID:31533062 Npr2 Rat tamoxifen increases expression ISO Npr2 (Mus musculus) 6480464 Tamoxifen results in increased expression of NPR2 mRNA CTD PMID:25123088 Npr2 Rat tamoxifen multiple interactions ISO NPR2 (Homo sapiens) 6480464 [Tamoxifen co-treated with ESR1 protein] results in increased expression of NPR2 mRNA and [Tamoxifen co-treated with ESR2 protein] results in decreased expression of NPR2 mRNA CTD PMID:19059307 Npr2 Rat tamoxifen affects expression ISO NPR2 (Homo sapiens) 6480464 Tamoxifen affects the expression of NPR2 mRNA CTD PMID:14699072 Npr2 Rat temozolomide decreases expression ISO NPR2 (Homo sapiens) 6480464 Temozolomide results in decreased expression of NPR2 mRNA CTD PMID:31758290 Npr2 Rat tetrachloromethane affects expression ISO Npr2 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of NPR2 mRNA CTD PMID:17484886 Npr2 Rat tetrachloromethane decreases expression ISO Npr2 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of NPR2 mRNA CTD PMID:27339419 more ... Npr2 Rat tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of NPR2 mRNA CTD PMID:16644059 Npr2 Rat tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of NPR2 mRNA CTD PMID:12734012 Npr2 Rat titanium dioxide decreases methylation ISO Npr2 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of NPR2 promoter CTD PMID:35295148 Npr2 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of NPR2 mRNA CTD PMID:33387578 Npr2 Rat trichostatin A decreases expression ISO NPR2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of NPR2 mRNA CTD PMID:24935251 Npr2 Rat triphenyl phosphate affects expression ISO NPR2 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of NPR2 mRNA CTD PMID:37042841 Npr2 Rat urethane decreases expression ISO NPR2 (Homo sapiens) 6480464 Urethane results in decreased expression of NPR2 mRNA CTD PMID:28818685 Npr2 Rat valproic acid affects expression ISO Npr2 (Mus musculus) 6480464 Valproic Acid affects the expression of NPR2 mRNA CTD PMID:17963808 Npr2 Rat valproic acid multiple interactions ISO NPR2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NPR2 mRNA CTD PMID:27188386 Npr2 Rat valproic acid decreases expression ISO NPR2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of NPR2 mRNA CTD PMID:23179753 more ... Npr2 Rat valproic acid increases expression ISO NPR2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of NPR2 mRNA CTD PMID:29154799 Npr2 Rat valproic acid affects expression ISO NPR2 (Homo sapiens) 6480464 Valproic Acid affects the expression of NPR2 mRNA CTD PMID:25979313 Npr2 Rat valproic acid decreases methylation ISO NPR2 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of NPR2 gene CTD PMID:29154799
Imported Annotations - KEGG (archival)
(1->4)-beta-D-glucan (ISO) 1,1-dichloroethene (ISO) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2-hydroxypropanoic acid (ISO) 3,3',4,4'-tetrachlorobiphenyl (ISO) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-sulfonyldiphenol (EXP,ISO) 4-hydroxyphenyl retinamide (ISO) 6-propyl-2-thiouracil (EXP) acrolein (ISO) afimoxifene (ISO) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) allethrin (EXP) amitrole (EXP) ammonia (EXP) ammonium chloride (EXP) amphetamine (EXP) aristolochic acid A (ISO) atrazine (EXP) benzo[a]pyrene (ISO) bisphenol A (EXP,ISO) bisphenol AF (EXP) bisphenol F (EXP,ISO) butanal (ISO) cadmium dichloride (EXP) carbamazepine (ISO) carbon nanotube (ISO) crocidolite asbestos (ISO) cyclosporin A (ISO) cyhalothrin (EXP) cypermethrin (EXP) dexamethasone (EXP,ISO) diazinon (ISO) Dibutyl phosphate (ISO) dibutyl phthalate (EXP) dioxygen (ISO) diuron (EXP) dorsomorphin (ISO) doxorubicin (ISO) endosulfan (EXP) epoxiconazole (ISO) ethanol (ISO) fenamidone (ISO) fenthion (ISO) fenvalerate (EXP) furan (EXP) indometacin (ISO) lead(0) (ISO) leflunomide (ISO) methimazole (EXP) methylisothiazolinone (ISO) N-nitrosodiethylamine (ISO) nickel atom (ISO) nickel sulfate (ISO) nitrofen (EXP) ozone (ISO) paracetamol (EXP,ISO) perfluorohexanesulfonic acid (ISO) perfluorooctane-1-sulfonic acid (ISO) phenobarbital (ISO) phosgene (ISO) pirinixic acid (ISO) potassium dichromate (ISO) pregnenolone 16alpha-carbonitrile (EXP) pyrethrins (EXP) rac-lactic acid (ISO) raloxifene (ISO) rofecoxib (ISO) SB 431542 (ISO) silver atom (ISO) silver(0) (ISO) sodium fluoride (ISO) sulfadimethoxine (EXP) sulforaphane (ISO) sunitinib (ISO) tamoxifen (ISO) temozolomide (ISO) tetrachloromethane (EXP,ISO) titanium dioxide (ISO) trichloroethene (EXP) trichostatin A (ISO) triphenyl phosphate (ISO) urethane (ISO) valproic acid (ISO)
Biological Process
activation of meiosis involved in egg activation (IEA,ISO) axonogenesis (IEA,ISO) axonogenesis involved in innervation (IEA,ISO) blood circulation (IEA,ISO) blood vessel development (IEA,ISO) blood vessel remodeling (IEA,ISO) bone development (IEA,ISO) bone growth (IEA,ISO) c-di-GMP signaling (IEA,ISO) cartilage development (IEA,ISO) cellular response to cGMP (IEA,ISO) cellular response to granulocyte macrophage colony-stimulating factor stimulus (IEA,ISO) cellular response to peptide (IEA,ISO) cGMP biosynthetic process (IBA,IEA,ISO) cGMP metabolic process (IEA,ISO) cGMP-mediated signaling (IDA) chemical synaptic transmission (IEA,ISO) chondrocyte differentiation (IEA,ISO) chondrocyte proliferation (IEA,ISO) chromosome organization (IEA,ISO) collateral sprouting (IEA,ISO) cumulus cell differentiation (IEA,ISO) cyclic nucleotide biosynthetic process (IEA) digestive tract development (IEA,ISO) digestive tract morphogenesis (IEA,ISO) endochondral ossification (IEA,ISO) epidermal growth factor receptor signaling pathway (IEA,ISO) execution phase of apoptosis (IEA,ISO) female genitalia development (IEA,ISO) gastric emptying (IEA,ISO) genitalia morphogenesis (IEA,ISO) germ cell development (IEA,ISO) growth plate cartilage development (IEA,ISO) intracellular signal transduction (IEA) limb development (IEA,ISO) limb morphogenesis (IEA,ISO) lymph vessel development (IEA,ISO) MAPK cascade (IEA,ISO) meiotic cell cycle (IEA,ISO) meiotic cell cycle process involved in oocyte maturation (IEA,ISO) multicellular organism growth (IEA,ISO) negative regulation of meiotic cell cycle (IEA,ISO) negative regulation of oocyte maturation (IEA,ISO) nerve development (IEA,ISO) neuron apoptotic process (IEA,ISO) neuronal action potential (IEA,ISO) oocyte development (IEA,ISO) ossification (IEA) ovarian follicle development (IEA,ISO) positive regulation of cGMP-mediated signaling (IDA) positive regulation of platelet-derived growth factor receptor signaling pathway (IMP) post-anal tail morphogenesis (IEA,ISO) receptor guanylyl cyclase signaling pathway (IBA,IEA,ISO,ISS) response to fibroblast growth factor (IEA,ISO) response to hormone (IEA,ISO) response to luteinizing hormone (IEA,ISO) response to salt (IEA,ISO) response to wounding (IEA,ISO) sensory perception of sound (IEA,ISO) single fertilization (IEA,ISO) smooth muscle tissue development (IEA,ISO) spermatogenesis (IEA,ISO) startle response (IEA,ISO) vacuole organization (IEA,ISO) vascular wound healing (IEA,ISO) vasculogenesis (IEA,ISO) vestibulocochlear nerve development (IEA,ISO) vestibulocochlear nerve maturation (IEA,ISO) white fat cell differentiation (IEA,ISO) wound healing (IMP)
1.
Natriuretic peptide receptor-B in adult rat ventricle is predominantly confined to the nonmyocyte population.
Doyle DD, etal., Am J Physiol Heart Circ Physiol. 2002 Jun;282(6):H2117-23.
2.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
3.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
4.
KEGG: Kyoto Encyclopedia of Genes and Genomes
KEGG
5.
Forced homodimerization by site-directed mutagenesis alters guanylyl cyclase activity of natriuretic peptide receptor B.
Langenickel T, etal., Hypertension. 2004 Feb;43(2):460-5. Epub 2003 Dec 22.
6.
Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B.
Langenickel TH, etal., Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4735-40. Epub 2006 Mar 14.
7.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
8.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
9.
OMIM Disease Annotation Pipeline
OMIM Disease Annotation Pipeline
10.
Neuropilins 1 and 2 mediate neointimal hyperplasia and re-endothelialization following arterial injury.
Pellet-Many C, etal., Cardiovasc Res. 2015 Nov 1;108(2):288-98. doi: 10.1093/cvr/cvv229. Epub 2015 Sep 25.
11.
KEGG Annotation Import Pipeline
Pipeline to import KEGG annotations from KEGG into RGD
12.
C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
Rahmutula D and Gardner DG, Endocrinology. 2005 Nov;146(11):4968-74. Epub 2005 Aug 18.
13.
Structure of the type B human natriuretic peptide receptor gene and association of a novel microsatellite polymorphism with essential hypertension.
Rehemudula D, etal., Circ Res. 1999 Mar 19;84(5):605-10.
14.
GOA pipeline
RGD automated data pipeline
15.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
16.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
17.
The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family.
Schulz S, etal., Cell 1989 Sep 22;58(6):1155-62.
18.
Detection of membrane-bound guanylate cyclase activity in rat C6 glioma cells at different growth states following activation by natriuretic peptides.
Sorci G, etal., Brain Res. 1995 Jun 12;683(1):51-8.
19.
A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn/cn mouse.
Tsuji T and Kunieda T, J Biol Chem. 2005 Apr 8;280(14):14288-92. Epub 2005 Feb 18.
Npr2 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 62,678,197 - 62,697,360 (+) NCBI GRCr8 mRatBN7.2 5 57,883,171 - 57,901,590 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 57,883,171 - 57,901,580 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 59,863,179 - 59,881,665 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 61,681,991 - 61,700,479 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 61,653,242 - 61,671,683 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 59,128,186 - 59,147,321 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 59,128,315 - 59,147,255 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 63,652,957 - 63,672,114 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 5 60,107,563 - 60,127,960 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 5 60,107,741 - 60,128,139 (+) NCBI Celera 5 56,463,705 - 56,482,048 (+) NCBI Celera Cytogenetic Map 5 q22 NCBI
NPR2 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 9 35,791,591 - 35,809,731 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 9 35,791,003 - 35,809,732 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 9 35,791,588 - 35,809,728 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 9 35,782,406 - 35,799,728 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 9 35,782,405 - 35,799,709 NCBI Celera 9 35,725,947 - 35,743,260 (+) NCBI Celera Cytogenetic Map 9 p13.3 NCBI HuRef 9 35,748,436 - 35,765,752 (+) NCBI HuRef CHM1_1 9 35,792,795 - 35,810,116 (+) NCBI CHM1_1 T2T-CHM13v2.0 9 35,777,317 - 35,830,398 (+) NCBI T2T-CHM13v2.0
Npr2 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 4 43,629,015 - 43,651,437 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 4 43,631,935 - 43,651,244 (+) Ensembl GRCm39 Ensembl GRCm38 4 43,629,015 - 43,651,437 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 4 43,631,935 - 43,651,244 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 4 43,644,807 - 43,664,116 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 4 43,653,035 - 43,672,344 (+) NCBI MGSCv36 mm8 Celera 4 43,666,379 - 43,685,849 (+) NCBI Celera Cytogenetic Map 4 A5 NCBI cM Map 4 23.05 NCBI
Npr2 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955472 506,351 - 523,316 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955472 506,351 - 523,647 (-) NCBI ChiLan1.0 ChiLan1.0
NPR2 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 11 88,779,098 - 88,796,792 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 9 88,785,250 - 88,802,729 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 9 35,642,534 - 35,660,210 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 9 36,445,576 - 36,462,637 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 9 36,445,576 - 36,462,637 (+) Ensembl panpan1.1 panPan2
NPR2 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 11 52,283,680 - 52,339,247 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 11 52,321,590 - 52,339,249 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 11 50,888,024 - 50,906,818 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 11 53,385,429 - 53,404,264 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 11 53,386,145 - 53,450,659 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 11 51,929,955 - 51,948,772 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 11 51,913,486 - 51,932,996 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 11 52,615,631 - 52,634,454 (+) NCBI UU_Cfam_GSD_1.0
Npr2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404947 167,231,815 - 167,250,482 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936524 3,779,392 - 3,798,501 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936524 3,779,398 - 3,798,074 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
NPR2 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 1 236,508,998 - 236,529,128 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 1 236,508,994 - 236,529,172 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 1 264,233,393 - 264,254,186 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
NPR2 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 12 44,795,822 - 44,844,464 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 12 44,793,253 - 44,813,671 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666038 41,900,466 - 41,949,193 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Npr2 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 38 Count of miRNA genes: 34 Interacting mature miRNAs: 36 Transcripts: ENSRNOT00000021802 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1578776 Stresp18 Stress response QTL 18 2.9 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 5 27955440 72955440 Rat 1298067 Scl15 Serum cholesterol level QTL 15 4.8 0.001 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 33215665 78215665 Rat 1300115 Hrtrt7 Heart rate QTL 7 2.76 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 5 47869062 90099692 Rat 1549845 Scl44 Serum cholesterol level QTL 44 6 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 5 40128307 148607290 Rat 70212 Niddm25 Non-insulin dependent diabetes mellitus QTL 25 3.54 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 5 1 131345958 Rat 1358353 Srcrtb2 Stress Responsive Cort Basal QTL 2 3.48 0.003 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 5 18873947 74251464 Rat 634305 Mamtr1 Mammary tumor resistance QTL 1 0.0001 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 12789751 113558310 Rat 1331801 Rf33 Renal function QTL 33 4.149 kidney blood vessel physiology trait (VT:0100012) absolute change in renal vascular resistance (CMO:0001900) 5 43726656 129132602 Rat 1598807 Glom12 Glomerulus QTL 12 2.7 kidney glomerulus morphology trait (VT:0005325) index of glomerular damage (CMO:0001135) 5 33215665 78215665 Rat 1302786 Kidm8 Kidney mass QTL 8 28.15 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 5 33215665 78215665 Rat 6903292 Stl28 Serum triglyceride level QTL 28 2.6 0.0073 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 5 28515489 73515489 Rat 1578766 Tcas11 Tongue tumor susceptibility QTL 11 4.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 5 46711509 161317411 Rat 1578767 Stresp17 Stress response QTL 17 4.3 0.01 blood aldosterone amount (VT:0005346) plasma aldosterone level (CMO:0000551) 5 27955440 72955440 Rat 7411561 Bw134 Body weight QTL 134 24 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 5 49463600 94463600 Rat 1641922 Alcrsp8 Alcohol response QTL 8 alcohol metabolism trait (VT:0015089) blood ethanol level (CMO:0000535) 5 35189153 68564008 Rat 2303615 Vencon7 Ventilatory control QTL 7 0.001 respiration trait (VT:0001943) respiration rate (CMO:0000289) 5 50983895 95983895 Rat 1576312 Emca8 Estrogen-induced mammary cancer QTL 8 4.1 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 50328551 141643988 Rat 1641912 Alcrsp18 Alcohol response QTL 18 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 5 35189153 141643988 Rat 1576314 Eutr1 Estrogen induced uterine response QTL 1 uterus integrity trait (VT:0010575) pyometritis severity score (CMO:0002009) 5 2138965 166875058 Rat 6903306 Scl35 Serum cholesterol QTL 35 2.6 0.0073 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 28515489 73515489 Rat 1576317 Eutr2 Estrogen induced uterine response QTL 2 0.01 uterus integrity trait (VT:0010575) pyometritis severity score (CMO:0002009) 5 34730116 104251008 Rat 7394712 Emca13 Estrogen-induced mammary cancer QTL 13 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 9823266 99753708 Rat 1331773 Scl26 Serum cholesterol level QTL 26 3.065 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 5 43726656 86724018 Rat 70189 Mcs5 Mammary carcinoma susceptibility QTL 5 10.51 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 55805606 132207589 Rat 1331771 Rf35 Renal function QTL 35 4.36965 kidney blood vessel physiology trait (VT:0100012) absolute change in renal blood flow rate (CMO:0001168) 5 729470 86724018 Rat 61359 Eaex Experimental allergic encephalomyelitis QTL x 3 nervous system integrity trait (VT:0010566) post-insult time to onset of experimental autoimmune encephalomyelitis (CMO:0001422) 5 55715622 100715622 Rat 8662454 Vetf3 Vascular elastic tissue fragility QTL 3 27.4 artery integrity trait (VT:0010639) number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries (CMO:0002562) 5 2282226 69540447 Rat 2290448 Scl54 Serum cholesterol level QTL 54 2.93 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 31663789 131345958 Rat 9589025 Epfw7 Epididymal fat weight QTL 7 20.66 0.001 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 5 49463600 94463600 Rat 2303574 Gluco42 Glucose level QTL 42 2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 5 53496719 98496719 Rat 1331756 Rf34 Renal function QTL 34 4.16275 kidney blood vessel physiology trait (VT:0100012) absolute change in renal blood flow rate (CMO:0001168) 5 1 90450412 Rat 8552954 Pigfal14 Plasma insulin-like growth factor 1 level QTL 14 9 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 5 21226744 66226744 Rat 2316959 Gluco59 Glucose level QTL 59 4.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 5 34944474 113558310 Rat 1600358 Mamtr5 Mammary tumor resistance QTL 5 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 18873947 63873947 Rat
BE097058
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 5 57,896,526 - 57,896,687 (+) MAPPER mRatBN7.2 Rnor_6.0 5 59,142,258 - 59,142,418 NCBI Rnor6.0 Rnor_5.0 5 63,667,050 - 63,667,210 UniSTS Rnor5.0 RGSC_v3.4 5 60,122,907 - 60,123,067 UniSTS RGSC3.4 Celera 5 56,476,995 - 56,477,155 UniSTS RH 3.4 Map 5 394.5 UniSTS Cytogenetic Map 5 q22 UniSTS
RH141203
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 5 57,901,764 - 57,901,982 (+) MAPPER mRatBN7.2 Rnor_6.0 5 59,147,496 - 59,147,713 NCBI Rnor6.0 Rnor_5.0 5 63,672,288 - 63,672,505 UniSTS Rnor5.0 RGSC_v3.4 5 60,128,145 - 60,128,362 UniSTS RGSC3.4 Celera 5 56,482,233 - 56,482,450 UniSTS RH 3.4 Map 5 395.0 UniSTS Cytogenetic Map 5 q22 UniSTS
RH141379
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 5 57,901,334 - 57,901,535 (+) MAPPER mRatBN7.2 Rnor_6.0 5 59,147,066 - 59,147,266 NCBI Rnor6.0 Rnor_5.0 5 63,671,858 - 63,672,058 UniSTS Rnor5.0 RGSC_v3.4 5 60,127,715 - 60,127,915 UniSTS RGSC3.4 Celera 5 56,481,803 - 56,482,003 UniSTS RH 3.4 Map 5 395.6 UniSTS Cytogenetic Map 5 q22 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000021802 ⟹ ENSRNOP00000021802
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 5 57,883,171 - 57,901,580 (+) Ensembl Rnor_6.0 Ensembl 5 59,128,315 - 59,147,255 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000112447 ⟹ ENSRNOP00000086809
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 5 57,883,171 - 57,901,580 (+) Ensembl
RefSeq Acc Id:
NM_053838 ⟹ NP_446290
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 62,678,942 - 62,697,350 (+) NCBI mRatBN7.2 5 57,883,171 - 57,901,580 (+) NCBI Rnor_6.0 5 59,128,903 - 59,147,311 (+) NCBI Rnor_5.0 5 63,652,957 - 63,672,114 (+) NCBI RGSC_v3.4 5 60,107,563 - 60,127,960 (+) RGD Celera 5 56,463,705 - 56,482,048 (+) RGD
Sequence:
GGCGCTTGTGCCTGCCCAGTAGGCCAGAGCAGCCCCTGGTTCGGGGGACCGTGGGTCAGCTGCTCTATCCCCATGGCACTGCCATCCCTGCTACTGGTGGTGGCAGCCCTGGCAGGTGGGGTGCGTCC TCCGGGGGCACGGAACCTGACGCTGGCGGTGGTGCTGCCAGAACACAACCTGAGCTATGCCTGGGCCTGGCCACGGGTGGGTCCTGCTGTGGCACTGGCTGTGGAGGCGCTGGGCCGGGCACTGCCCG TGGACCTGCGGTTTGTCAGCTCCGAACTAGACGGCGCCTGCTCTGAGTACCTGGCACCACTGCGCGCTGTGGATCTCAAGCTGTACCATGACCCCGACCTTCTGTTGGGCCCTGGTTGTGTGTACCCT GCTGCCTCTGTGGCTCGCTTTGCCTCGCACTGGCACCTTCCCCTCCTGACTGCGGGTGCAGTGGCCTCTGGCTTTGCAGCTAAGAATGAGCATTATCGTACCCTGGTTCGCACTGGCCCCTCTGCGCC CAAGCTGGGTGAGTTCGTAGTGACATTACACGGGCACTTCAATTGGACTGCTCGGGCTGCTTTGCTGTATCTGGATGCTCGCACAGATGACCGGCCCCACTACTTCACCATCGAGGGGGTGTTTGAGG CCCTGCAGGGCAGCAACCTCAGTGTGCAACACCAGGTGTATACCCGAGAGCCAGGTGGCCCTGAGCAAGCCACCCACTTCATCAGAGCCAACGGGCGCATTGTGTATATCTGCGGCCCGCTGGAGATG CTTCATGAGATCCTGCTTCAGGCCCAGAGGGAGAACCTGACCAATGGGGACTATGTCTTCTTTTACCTTGATGTCTTTGGGGAGAGTCTACGAGCAGGCCCCACACGTGCGACAGGCCGGCCATGGCA GGACAATCGAACCCAGGAACAAGCTCAGGCCCTCAGAGAGGCCTTTCAGACTGTCCTGGTGATCACGTACCGAGAGCCCCCGAATCCCGAGTATCAGGAGTTCCAGAACCGCCTGCTGATCAGAGCCC GGGAAGACTTCGGCGTGGAGCTGGCCCCATCCCTGATGAACCTCATTGCGGGCTGCTTCTATGATGGAATCCTGCTCTATGCCCAAGTCCTGAATGAGACAATACAGGAAGGGGGCACCCGGGAAGAT GGACTTCGAATTGTGGAGAAGATGCAGGGACGAAGATACCATGGTGTAACTGGACTGGTTGTTATGGACAAGAACAATGACAGAGAGACTGATTTCGTCCTGTGGGCCATGGGAGACTTGGAGTCTGG CGACTTTCAGCCTGCAGCCCATTACTCAGGAGCTGAGAAGCAGATTTGGTGGACAGGCCGGCCAATTCCCTGGGTGAAGGGGGCCCCACCTTTGGACAACCCCCCCTGTGCCTTTGACTTGGACGACC CATCCTGTGATAAAACTCCACTTTCCACTCTGGCAATTGTGGCCCTGGGCACGGGAATCACTTTCATCATGTTTGGTGTTTCCAGCTTCCTAATTTTCCGAAAACTGATGCTGGAGAAGGAGCTGGCT AGCATGCTGTGGCGCATTCGCTGGGAAGAACTGCAGTTCGGCAACTCGGATCGATATCACAAAGGTGCAGGCAGTCGCCTGACGCTGTCGCTGCGGGGATCCAGTTACGGCTCGCTCATGACAGCCCA TGGGAAATACCAGATCTTTGCCAACACCGGTCACTTCAAGGGAAATGTCGTTGCCATCAAACATGTGAATAAGAAGCGCATTGAGCTGACCCGGCAAGTTCTGTTTGAACTCAAACACATGAGAGATG TTCAGTTCAACCATCTTACTCGATTCATCGGAGCTTGCATAGACCCTCCCAACATCTGCATCGTCACCGAGTATTGTCCTCGGGGGAGCTTACAAGATATTCTAGAAAATGACAGCATCAATTTGGAC TGGATGTTTCGCTACTCGCTCATTAATGACCTTGTGAAGGGTATGGCCTTTCTCCACAACAGCATTATTTCATCTCATGGAAGCCTCAAGTCCTCTAACTGCGTGGTGGATAGTCGATTTGTGCTCAA AATAACGGATTACGGGCTGGCTAGCTTCCGATCAACTGCTGAACCAGATGACAGTCATGCCCTCTATGCCAAGAAGCTGTGGACTGCTCCAGAACTTCTTAGTGGGAACCCCCTGCCAACCACGGGCA TGCAGAAGGCGGATGTCTATAGCTTTGCCATCATTCTGCAGGAAATAGCGCTCCGCAGTGGTCCTTTCTACTTGGAAGGCCTGGACCTCAGTCCCAAAGAGATTGTCCAGAAGGTGCGAAATGGTCAG AGGCCGTATTTCCGGCCAAGCATTGACCGGACACAACTGAACGAAGAGTTAGTTTTGCTGATGGAGAGGTGCTGGGCCCAGGACCCAACAGAACGTCCAGACTTTGGGCAAATCAAGGGCTTCATTCG CCGGTTTAACAAGGAGGGTGGTACCAGCATATTGGACAACCTCTTGCTTCGCATGGAACAGTATGCCAATAACCTGGAAAAACTGGTGGAGGAGCGCACACAGGCCTACCTAGAGGAGAAGCGCAAGG CTGAGGCTCTGCTGTACCAAATTCTACCCCACTCTGTGGCAGAGCAGTTAAAACGGGGAGAGACGGTTCAGGCGGAGGCCTTTGACAGTGTCACTATCTACTTCAGTGACATCGTGGGCTTCACAGCG CTGTCAGCTGAGAGCACCCCCATGCAGGTGGTGACACTTCTTAATGACCTTTATACCTGCTTTGATGCCATAATCGACAACTTTGATGTCTACAAGGTGGAAACCATTGGGGATGCCTACATGGTGGT ATCTGGCCTTCCGGGCCGAAATGGTCAGCGCCATGCACCAGAAATTGCTCGAATGGCTCTAGCATTACTAGATGCAGTTTCTTCCTTCCGCATTCGCCATCGACCCCACGACCAGCTAAGGTTACGCA TAGGCGTCCATACTGGGCCAGTCTGTGCTGGGGTTGTTGGCCTGAAGATGCCCCGGTACTGTCTTTTTGGAGACACAGTAAACACTGCTTCTCGAATGGAGTCTAATGGTCAAGCTCTAAAGATCCAT GTCTCCTCGACCACCAAGGATGCCCTGGATGAGCTAGGATGCTTCCAGCTAGAACTCCGTGGGGATGTGGAGATGAAGGGAAAAGGAAAAATGCGAACTTATTGGCTCTTAGGAGAGCGAAAAGGACC TCCTGGACTCCTGTAAATCCCAAGCAGACAATTTCTTGCTGTTGGTACTTGGATGGGCAATGGTCACTGTGTCTCCACTTGACAGAAACAGACGTCATATGAGATGGAAAATATGCATATACACAATC CCCCTGCCTTATCTGGAAGTCATATAAGCCCTCTGCCGCTCAGCCTTGTACATATGCCTGCCCCTCCCTATCTTGGTCCTCTTCCTGCCTTCTGTAAATACCTGTATCTAGACCAGAATATTTTGTCC AAGTATAAAACAA
hide sequence
RefSeq Acc Id:
XM_006238010 ⟹ XP_006238072
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 62,678,197 - 62,697,360 (+) NCBI mRatBN7.2 5 57,883,207 - 57,901,590 (+) NCBI Rnor_6.0 5 59,128,186 - 59,147,321 (+) NCBI Rnor_5.0 5 63,652,957 - 63,672,114 (+) NCBI
Sequence:
CGGGCGCAGCGAGCGGAGACGCGCCGGGCCGAGGCGACCTGACCTGGACGAGCGGCGCGCGCGG GGGCCCAGGCGGGGGGCGGGAGGCAGCGCCGGGCAGCGCGGGCCGCGGGGCCCGGGAGAAGCGGAGCCGAGAGGAGCGGGGTACACGGGCGGGGCTGCCGCAGCTCCGGATAGGACCAGCGCCCCGGC CCGTTAGCCCAGGCAGGAGCTTCAGGAGAAGCCGTCACTGGGAGAGTCACCCCTGCCTTTCCCTCCCCTCTGGCCCAGGCCTCGCTTCGCTCCCTGCCTGCCCATGTCCCAGTCCTTCCGCGCCGGGC GCCCTCCCACCTCAGCCCGGGGCTTTGGCTTTTCGCAGCTCTTTGCCCTCCAGGCCGGGTCAGCTGTGAGGTGTCCCCAGGCCGTTTCTTTGTACCAGCCTCCCCCAAGTCCCTACCCCATCCCAGGC TCATATCCCCCCCTTCTTGGCTTGGGATTGTCAGGCTACTTCACCTCTCACTGTCCTCATCCCCGTCGCAGGCCCCCTTGGTCCCTTCCTCCCTCTGCCACCCTATCCTTAGTCCTTGGACCTTGCTG TAGGCTGGTAGCCCACTCCTTCCCGTCCCAGGCTTCCCCCCATCCTCTTCTTTCGTGGTCCCCAGCACTTTCCGTATCCAGGCCGACTAAGCTTGTCCCCACTTCTCTTCCTGGCCCTCTTCCCCAGA CTCCAGGCTGGGTGGCGCTTGTGCCTGCCCAGTAGGCCAGAGCAGCCCCTGGTTCGGGGGACCGTGGGTCAGCTGCTCTATCCCCATGGCACTGCCATCCCTGCTACTGGTGGTGGCAGCCCTGGCAG GTGGGGTGCGTCCTCCGGGGGCACGGAACCTGACGCTGGCGGTGGTGCTGCCAGAACACAACCTGAGCTATGCCTGGGCCTGGCCACGGGTGGGTCCTGCTGTGGCACTGGCTGTGGAGGCGCTGGGC CGGGCACTGCCCGTGGACCTGCGGTTTGTCAGCTCCGAACTAGACGGCGCCTGCTCTGAGTACCTGGCACCACTGCGCGCTGTGGATCTCAAGCTGTACCATGACCCCGACCTTCTGTTGGGCCCTGG TTGTGTGTACCCTGCTGCCTCTGTGGCTCGCTTTGCCTCGCACTGGCACCTTCCCCTCCTGACTGCGGGTGCAGTGGCCTCTGGCTTTGCAGCTAAGAATGAGCATTATCGTACCCTGGTTCGCACTG GCCCCTCTGCGCCCAAGCTGGGTGAGTTCGTAGTGACATTACACGGGCACTTCAATTGGACTGCTCGGGCTGCTTTGCTGTATCTGGATGCTCGCACAGATGACCGGCCCCACTACTTCACCATCGAG GGGGTGTTTGAGGCCCTGCAGGGCAGCAACCTCAGTGTGCAACACCAGGTGTATACCCGAGAGCCAGGTGGCCCTGAGCAAGCCACCCACTTCATCAGAGCCAACGGGCGCATTGTGTATATCTGCGG CCCGCTGGAGATGCTTCATGAGATCCTGCTTCAGGCCCAGAGGGAGAACCTGACCAATGGGGACTATGTCTTCTTTTACCTTGATGTCTTTGGGGAGAGTCTACGAGCAGGCCCCACACGTGCGACAG GCCGGCCATGGCAGGACAATCGAACCCAGGAACAAGCTCAGGCCCTCAGAGAGGCCTTTCAGACTGTCCTGGTGATCACGTACCGAGAGCCCCCGAATCCCGAGTATCAGGAGTTCCAGAACCGCCTG CTGATCAGAGCCCGGGAAGACTTCGGCGTGGAGCTGGCCCCATCCCTGATGAACCTCATTGCGGGCTGCTTCTATGATGGAATCCTGCTCTATGCCCAAGTCCTGAATGAGACAATACAGGAAGGGGG CACCCGGGAAGATGGACTTCGAATTGTGGAGAAGATGCAGGGACGAAGATACCATGGTGTAACTGGACTGGTTGTTATGGACAAGAACAATGACAGAGAGACTGATTTCGTCCTGTGGGCCATGGGAG ACTTGGAGTCTGGCGACTTTCAGCCTGCAGCCCATTACTCAGGAGCTGAGAAGCAGATTTGGTGGACAGGCCGGCCAATTCCCTGGGTGAAGGGGGCCCCACCTTTGGACAACCCCCCCTGTGCCTTT GACTTGGACGACCCATCCTGTGATAAAACTCCACTTTCCACTCTGGCAATTGTGGCCCTGGGCACGGGAATCACTTTCATCATGTTTGGTGTTTCCAGCTTCCTAATTTTCCGAAAACTGATGCTGGA GAAGGAGCTGGCTAGCATGCTGTGGCGCATTCGCTGGGAAGAACTGCAGTTCGGCAACTCGGATCGATATCACAAAGGTGCAGGCAGTCGCCTGACGCTGTCGCTGGGAAATGTCGTTGCCATCAAAC ATGTGAATAAGAAGCGCATTGAGCTGACCCGGCAAGTTCTGTTTGAACTCAAACACATGAGAGATGTTCAGTTCAACCATCTTACTCGATTCATCGGAGCTTGCATAGACCCTCCCAACATCTGCATC GTCACCGAGTATTGTCCTCGGGGGAGCTTACAAGATATTCTAGAAAATGACAGCATCAATTTGGACTGGATGTTTCGCTACTCGCTCATTAATGACCTTGTGAAGGGTATGGCCTTTCTCCACAACAG CATTATTTCATCTCATGGAAGCCTCAAGTCCTCTAACTGCGTGGTGGATAGTCGATTTGTGCTCAAAATAACGGATTACGGGCTGGCTAGCTTCCGATCAACTGCTGAACCAGATGACAGTCATGCCC TCTATGCCAAGAAGCTGTGGACTGCTCCAGAACTTCTTAGTGGGAACCCCCTGCCAACCACGGGCATGCAGAAGGCGGATGTCTATAGCTTTGCCATCATTCTGCAGGAAATAGCGCTCCGCAGTGGT CCTTTCTACTTGGAAGGCCTGGACCTCAGTCCCAAAGAGATTGTCCAGAAGGTGCGAAATGGTCAGAGGCCGTATTTCCGGCCAAGCATTGACCGGACACAACTGAACGAAGAGTTAGTTTTGCTGAT GGAGAGGTGCTGGGCCCAGGACCCAACAGAACGTCCAGACTTTGGGCAAATCAAGGGCTTCATTCGCCGGTTTAACAAGGAGGGTGGTACCAGCATATTGGACAACCTCTTGCTTCGCATGGAACAGT ATGCCAATAACCTGGAAAAACTGGTGGAGGAGCGCACACAGGCCTACCTAGAGGAGAAGCGCAAGGCTGAGGCTCTGCTGTACCAAATTCTACCCCACTCTGTGGCAGAGCAGTTAAAACGGGGAGAG ACGGTTCAGGCGGAGGCCTTTGACAGTGTCACTATCTACTTCAGTGACATCGTGGGCTTCACAGCGCTGTCAGCTGAGAGCACCCCCATGCAGGTGGTGACACTTCTTAATGACCTTTATACCTGCTT TGATGCCATAATCGACAACTTTGATGTCTACAAGGTGGAAACCATTGGGGATGCCTACATGGTGGTATCTGGCCTTCCGGGCCGAAATGGTCAGCGCCATGCACCAGAAATTGCTCGAATGGCTCTAG CATTACTAGATGCAGTTTCTTCCTTCCGCATTCGCCATCGACCCCACGACCAGCTAAGGTTACGCATAGGCGTCCATACTGGGCCAGTCTGTGCTGGGGTTGTTGGCCTGAAGATGCCCCGGTACTGT CTTTTTGGAGACACAGTAAACACTGCTTCTCGAATGGAGTCTAATGGTCAAGCTCTAAAGATCCATGTCTCCTCGACCACCAAGGATGCCCTGGATGAGCTAGGATGCTTCCAGCTAGAACTCCGTGG GGATGTGGAGATGAAGGGAAAAGGAAAAATGCGAACTTATTGGCTCTTAGGAGAGCGAAAAGGACCTCCTGGACTCCTGTAAATCCCAAGCAGACAATTTCTTGCTGTTGGTACTTGGATGGGCAATG GTCACTGTGTCTCCACTTGACAGAAACAGACGTCATATGAGATGGAAAATATGCATATACACAATCCCCCTGCCTTATCTGGAAGTCATATAAGCCCTCTGCCGCTCAGCCTTGTACATATGCCTGCC CCTCCCTATCTTGGTCCTCTTCCTGCCTTCTGTAAATACCTGTATCTAGACCAGAATATTTTGTCCAAGTATAAAACAACAACAACAAA
hide sequence
RefSeq Acc Id:
XM_063287066 ⟹ XP_063143136
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 62,687,999 - 62,697,360 (+) NCBI
RefSeq Acc Id:
NP_446290 ⟸ NM_053838
- Peptide Label:
precursor
- UniProtKB:
P16067 (UniProtKB/Swiss-Prot), A6IJ41 (UniProtKB/TrEMBL)
- Sequence:
MALPSLLLVVAALAGGVRPPGARNLTLAVVLPEHNLSYAWAWPRVGPAVALAVEALGRALPVDLRFVSSELDGACSEYLAPLRAVDLKLYHDPDLLLGPGCVYPAASVARFASHWHLPLLTAGAVASG FAAKNEHYRTLVRTGPSAPKLGEFVVTLHGHFNWTARAALLYLDARTDDRPHYFTIEGVFEALQGSNLSVQHQVYTREPGGPEQATHFIRANGRIVYICGPLEMLHEILLQAQRENLTNGDYVFFYLD VFGESLRAGPTRATGRPWQDNRTQEQAQALREAFQTVLVITYREPPNPEYQEFQNRLLIRAREDFGVELAPSLMNLIAGCFYDGILLYAQVLNETIQEGGTREDGLRIVEKMQGRRYHGVTGLVVMDK NNDRETDFVLWAMGDLESGDFQPAAHYSGAEKQIWWTGRPIPWVKGAPPLDNPPCAFDLDDPSCDKTPLSTLAIVALGTGITFIMFGVSSFLIFRKLMLEKELASMLWRIRWEELQFGNSDRYHKGAG SRLTLSLRGSSYGSLMTAHGKYQIFANTGHFKGNVVAIKHVNKKRIELTRQVLFELKHMRDVQFNHLTRFIGACIDPPNICIVTEYCPRGSLQDILENDSINLDWMFRYSLINDLVKGMAFLHNSIIS SHGSLKSSNCVVDSRFVLKITDYGLASFRSTAEPDDSHALYAKKLWTAPELLSGNPLPTTGMQKADVYSFAIILQEIALRSGPFYLEGLDLSPKEIVQKVRNGQRPYFRPSIDRTQLNEELVLLMERC WAQDPTERPDFGQIKGFIRRFNKEGGTSILDNLLLRMEQYANNLEKLVEERTQAYLEEKRKAEALLYQILPHSVAEQLKRGETVQAEAFDSVTIYFSDIVGFTALSAESTPMQVVTLLNDLYTCFDAI IDNFDVYKVETIGDAYMVVSGLPGRNGQRHAPEIARMALALLDAVSSFRIRHRPHDQLRLRIGVHTGPVCAGVVGLKMPRYCLFGDTVNTASRMESNGQALKIHVSSTTKDALDELGCFQLELRGDVE MKGKGKMRTYWLLGERKGPPGLL
hide sequence
RefSeq Acc Id:
XP_006238072 ⟸ XM_006238010
- Peptide Label:
isoform X1
- UniProtKB:
A0A8L2UJL6 (UniProtKB/TrEMBL), A6IJ41 (UniProtKB/TrEMBL)
- Sequence:
MALPSLLLVVAALAGGVRPPGARNLTLAVVLPEHNLSYAWAWPRVGPAVALAVEALGRALPVDL RFVSSELDGACSEYLAPLRAVDLKLYHDPDLLLGPGCVYPAASVARFASHWHLPLLTAGAVASGFAAKNEHYRTLVRTGPSAPKLGEFVVTLHGHFNWTARAALLYLDARTDDRPHYFTIEGVFEALQ GSNLSVQHQVYTREPGGPEQATHFIRANGRIVYICGPLEMLHEILLQAQRENLTNGDYVFFYLDVFGESLRAGPTRATGRPWQDNRTQEQAQALREAFQTVLVITYREPPNPEYQEFQNRLLIRARED FGVELAPSLMNLIAGCFYDGILLYAQVLNETIQEGGTREDGLRIVEKMQGRRYHGVTGLVVMDKNNDRETDFVLWAMGDLESGDFQPAAHYSGAEKQIWWTGRPIPWVKGAPPLDNPPCAFDLDDPSC DKTPLSTLAIVALGTGITFIMFGVSSFLIFRKLMLEKELASMLWRIRWEELQFGNSDRYHKGAGSRLTLSLGNVVAIKHVNKKRIELTRQVLFELKHMRDVQFNHLTRFIGACIDPPNICIVTEYCPR GSLQDILENDSINLDWMFRYSLINDLVKGMAFLHNSIISSHGSLKSSNCVVDSRFVLKITDYGLASFRSTAEPDDSHALYAKKLWTAPELLSGNPLPTTGMQKADVYSFAIILQEIALRSGPFYLEGL DLSPKEIVQKVRNGQRPYFRPSIDRTQLNEELVLLMERCWAQDPTERPDFGQIKGFIRRFNKEGGTSILDNLLLRMEQYANNLEKLVEERTQAYLEEKRKAEALLYQILPHSVAEQLKRGETVQAEAF DSVTIYFSDIVGFTALSAESTPMQVVTLLNDLYTCFDAIIDNFDVYKVETIGDAYMVVSGLPGRNGQRHAPEIARMALALLDAVSSFRIRHRPHDQLRLRIGVHTGPVCAGVVGLKMPRYCLFGDTVN TASRMESNGQALKIHVSSTTKDALDELGCFQLELRGDVEMKGKGKMRTYWLLGERKGPPGLL
hide sequence
Ensembl Acc Id:
ENSRNOP00000021802 ⟸ ENSRNOT00000021802
Ensembl Acc Id:
ENSRNOP00000086809 ⟸ ENSRNOT00000112447
RefSeq Acc Id:
XP_063143136 ⟸ XM_063287066
- Peptide Label:
isoform X2
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2014-03-07
Npr2
natriuretic peptide receptor 2
Npr2
natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B)
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-10-10
Npr2
natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B)
Npr2
natriuretic peptide receptor 2
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2004-02-26
Npr2
natriuretic peptide receptor 2
Symbol and Name status set to approved
625702
APPROVED
2002-08-07
Npr2
natriuretic peptide receptor 2
Symbol and Name status set to provisional
70820
PROVISIONAL
Note Type
Note
Reference
gene_homology
has 78% identity to npr1 receptor
728952